Aims: Diabetes occurs more frequently in patients with pancreatic cancer than in the general population, and it has repeatedly been claimed that it is a risk factor for this tumor. However in most of the studies on this subject the duration of diabetes before the diagnosis of pancreatic cancer was not ascertained. In an attempt to clarify the cause of the association between these two pathologic conditions and to determine whether diabetes is a risk factor for pancreatic cancer we recently studied this association in a large number of patients with pancreatic cancer. Methods: A total of 720 patients with newly diagnosed pancreatic cancer (415 men and 305 women; mean age 62.6 years, range 22 to 79 years) and 720 controls matched for sex, age, social class, and geographic region, were enrolled in the study. All subjects were interviewed personally and in detail about their clinical history. The diagnosis of diabetes was based on criteria recommended by the American Diabetes Association. Results: One hundred sixty-four patients with pancreatic cancer (22.8 %) and 60 controls (8.3 %) had diabetes. In the majority of the patients with pancreatic cancer (56.1 %), diabetes was diagnosed either concomitantly with the cancer (in 40.2 %), or within two years before the diagnosis of cancer (in 15.9 %). The association between the two conditions was significant (odds ratio, 3.04; 95 % confidence interval, 2.21 to 4.17). However, when only patients with diabetes of three or more years' duration were considered, the association was no longer significant (odds ratio, 1.43; 95 % confidence interval, 0.98 to 2.07). All the patients with pancreatic cancer whose diabetes had been diagnosed before the cancer had non-insulin-dependent diabetes; all but one of the control patients with diabetes had the non-insulin-dependent form of the disease.
Introduction
The studies done involving diabetes and pancreatic cancer are numerous and the results are contradictory. Many conclude that diabetes is a risk factor for pancreatic cancer [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] and others, instead, conclude that it is not [15] [16] [17] [18] [19] [20] [21] . An important fault of those who say that diabetes is a risk factor for pancreatic cancer is that besides basing their conclusions on relatively few cases, they do not indicate, with precision, how many years the patients had had diabetes before the diagnosis of the tumor. In an attempt to clarify the relationship between diabetes and pancreatic cancer, and in particular to answer the question as to whether or not diabetes in patients with pancreatic cancer is a preexisting condition or secondary to the tumor, we recently studied the relationship between these two conditions [22] . An important goal in our study was to include a very large number of patients with pancreatic cancer.
Patients and methods
Our work involved 14 hospitals with experience in the management of pancreatic diseases. All study subjects were patients who were hospitalized in 13 of the study centers between January 1987 and December 1989 and in the 14th center, in Bologna, between January 1987 and December 1992. We studied 720 patients (415 men and 305 women; the mean age was 62.2 years, range 22 to 79 years). The diagnosis of pancreatic cancer was confirmed by histologic findings in 512 of the patients (71%) and by surgery in 48 (7%); in the other 160 patients (22%), the diagnosis was confirmed by typical findings on at least three imaging procedures, as well as by the clinical course. For each patient, a control subject matched for sex, age, social class.and geographic region was selected at random from the patients hospitalized at the same time in the same facility for acute non-malignant disorders. All the study subjects were interviewed personally about their medical history; special attention was paid to the presence of diabetes, the patient's age at the time of diagnosis, the type of diabetes, and the treatment received for it. Members of the immediate family were also interviewed in most cases. The diagnosis of diabetes was based on the criteria recommended by the American Diabetes Association.
Results
The results showed that 164 patients (96 men and 68 women) with pancreatic cancer had diabetes (22.8 %), as did 60 patients (30 men and 30 women) without pancreatic cancer (8.3 %). There was a family history of diabetes in 67 of the 164 patients with diabetes (40.9 %) and in 24 of the 60 controls with diabetes (40.0%). Table 1 shows the distribution of cases and controls according to the clinical duration of diabetes. In 92 of the 164 cases (56.1 %), diabetes was diagnosed either at the same time as the pancreatic cancer (40.2 %) or within two years before the diagnosis of cancer (15.9 %). The diagnosis of diabetes preceded the diagnosis of pancreatic cancer by 3 to 4 years in 11 cases (6.7 %), by 5 to 9 years in 27 (16.5 %), and by 10 or more years in 34 (20.7 %). The frequency of recent-onset diabetes (zero to two years' duration) was significantly higher in the patients than in the controls (56.0 %vs. 13.3 %,?<0.001). Table 2 shows some of the clinical characteristics of the patients with pancreatic cancer who had diabetes of recent onset and those without diabetes. There were no significant differences between the two groups in sex, age at the time of the diagnosis of pancreatic cancer, or location of the tumor. In the group of patients with a recent diagnosis of diabetes, a family history of diabetes was significantly more frequent (P = 0.003). Table 3 shows the estimated odds ratios according to the duration of diabetes. When all case patients with diabetes were considered, a significant association between diabetes and pancreatic cancer was found (odds ratio, 3.04; 95% confidence interval, 2.21 to 4.17). However, the association was not significant in patients with diabetes of three or more years' duration (odds ratio, 1.43; 95 % confidence interval, 0.98 to 2.07). This decline in the risk of pancreatic cancer was more rapid among the women than among the men: for women (Table 4) , the estimated risk fell below the level of significance with diabetes of one or more years' duration (odds ratio, 1.38; 95 % confidence interval, 0.83 to 2.30); for men (Table 5) , it was of borderline significance with diabetes of three or more years' duration (odds ratio, 1.75; 95 % confidence interval, 1.06 to 2.89) and fell below the level of significance only with diabetes of seven or more years' duration (odds ratio, 1.71; 95 % confidence interval, 0.94 to 3.11). Among women, men, and both sexes combined, the odds ratio was less than 1 for diabetes of 15 or more years' duration. All the patients with pancreatic cancer in whom diabetes had been recognized before the tumor were considered to have non-insulin dependent diabetes. Among the controls with diabetes, all had the noninsulin-dependent form of the disease except one, who had insulin-dependent diabetes. 
Discussion
We found a significant association between diabetes and pancreatic cancer. However, we found no association between diabetes and pancreatic cancer among patients with long-standing diabetes. The increased prevalence of diabetes in patients with pancreatic cancer is apparently due largely to diabetes of recent-onset, presumably caused by the tumor. Many studies [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] have concluded that diabetes is a risk factor for pancreatic cancer. However, the duration of the diabetes before the diagnosis of pancreatic cancer was not ascertained in these investigations. Other methodologic differences between our study and earlier work include the small numbers of patients, the use of mailed questionnaires and death certificates, and possibly unrepresentative control groups in previous studies. In our patients with pancreatic cancer who had diabetes that was diagnosed at the same time as or shortly before the tumor, it is likely that the diabetes was a consequence of the tumor. Pancreatic cancer can cause diabetes by destroying islet cells [23] or by causing peripheral resistance to insulin [24] . The factor responsible for this resistance seems to be islet amyloid polypeptide, whose concentrations are elevated in patients with pancreatic cancer who have diabetes [24] . Recently it has been shown that a soluble factor from pancreatic cancer cells selectively stimulates amylin secretion from islet cells, explaining the excessive amylin secretion found in pancreatic cancer [25] . Such insulin resistance occurs early in the course of the disease [26, 27] , which may explain why diabetes can appear before the symptoms of the pancreatic tumor. Recently, studies in isolated rat hepatocytes showed that an unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism, further supporting the hypothesis that pancreatic cancer is the cause rather than the consequence of diabetes mellitus [28] .
In our study [22] , the patients with pancreatic cancer in whom the diagnosis of diabetes preceded the diagnosis of cancer were considered to have non-insulin-dependent diabetes. All the controls with diabetes also had the noninsulin-dependent form of the disease except one, who had insulin-dependent diabetes. The prevalence of diabetes in our control subjects (8.3 %) was similar to that reported in the Italian population of a corresponding age (7 %). We did not use the glucosetolerance test to diagnose diabetes; for this reason, we may have underestimated the percentages of patients with diabetes.
In conclusion, the results of our study clearly show that diabetes in patients with pancreatic cancer is frequently of recent onset and is presumably caused by the tumor. Diabetes is not a risk factor for pancreatic cancer.
